Fahim Abbasi1, Christine Blasey, Gerald M Reaven. 1. Division of Cardiovascular Medicine, Department of Medicine and the Department of Psychiatry, Stanford University School of Medicine, Stanford, CA 94305, USA. fahim@stanford.edu
Abstract
BACKGROUND: It has been suggested that the cardiometabolic risk associated with excess adiposity is particularly related to central obesity. OBJECTIVE: The objective was to compare the associations between cardiometabolic risk of apparently healthy individuals and measures of central obesity [waist circumference (WC)] and overall obesity [body mass index (BMI)]. DESIGN: In this cross-sectional, observational study, 492 subjects (306 women and 303 non-Hispanic whites) were classified by BMI (in kg/m²) as normal weight (BMI <25) or overweight/obese (BMI = 25.0-34.9) and as having an abnormal WC (≥80 cm in women and ≥94 cm in men) or a normal WC (<80 cm in women and <94 cm in men). Measurements were also made of the cardiometabolic risk factors age, systolic blood pressure (SBP), and fasting plasma glucose (FPG), triglyceride, and high-density lipoprotein (HDL)-cholesterol concentrations. Associations among cardiometabolic risk factors and BMI and WC were evaluated with Pearson correlations. RESULTS: There was a considerable overlap in the normal and abnormal categories of BMI and WC, and ~81% of the subjects had both an abnormal BMI and WC. In women, BMI and WC correlated with SBP (r = 0.30 and 0.19, respectively), FPG (r = 0.25 and 0.22, respectively), triglycerides (r = 0.17 and 0.20, respectively), and HDL cholesterol (r = -0.23 and -0.20, respectively) (P < 0.01 for all). In men, BMI and WC also correlated with SBP (r = 0.22 and 0.22, respectively), FPG (r = 0.22 and 0.25, respectively), triglycerides (r = 0.21 and 0.18, respectively), and HDL cholesterol (r = -0.20 and -0.13, respectively) [P < 0.05 for all, except for the association of WC with HDL cholesterol (P = 0.08)]. CONCLUSIONS: Most individuals with an abnormal BMI also have an abnormal WC. Both indexes of excess adiposity are positively associated with SBP, FPG, and triglycerides and inversely associated with HDL cholesterol.
BACKGROUND: It has been suggested that the cardiometabolic risk associated with excess adiposity is particularly related to central obesity. OBJECTIVE: The objective was to compare the associations between cardiometabolic risk of apparently healthy individuals and measures of central obesity [waist circumference (WC)] and overall obesity [body mass index (BMI)]. DESIGN: In this cross-sectional, observational study, 492 subjects (306 women and 303 non-Hispanic whites) were classified by BMI (in kg/m²) as normal weight (BMI <25) or overweight/obese (BMI = 25.0-34.9) and as having an abnormal WC (≥80 cm in women and ≥94 cm in men) or a normal WC (<80 cm in women and <94 cm in men). Measurements were also made of the cardiometabolic risk factors age, systolic blood pressure (SBP), and fasting plasma glucose (FPG), triglyceride, and high-density lipoprotein (HDL)-cholesterol concentrations. Associations among cardiometabolic risk factors and BMI and WC were evaluated with Pearson correlations. RESULTS: There was a considerable overlap in the normal and abnormal categories of BMI and WC, and ~81% of the subjects had both an abnormal BMI and WC. In women, BMI and WC correlated with SBP (r = 0.30 and 0.19, respectively), FPG (r = 0.25 and 0.22, respectively), triglycerides (r = 0.17 and 0.20, respectively), and HDL cholesterol (r = -0.23 and -0.20, respectively) (P < 0.01 for all). In men, BMI and WC also correlated with SBP (r = 0.22 and 0.22, respectively), FPG (r = 0.22 and 0.25, respectively), triglycerides (r = 0.21 and 0.18, respectively), and HDL cholesterol (r = -0.20 and -0.13, respectively) [P < 0.05 for all, except for the association of WC with HDL cholesterol (P = 0.08)]. CONCLUSIONS: Most individuals with an abnormal BMI also have an abnormal WC. Both indexes of excess adiposity are positively associated with SBP, FPG, and triglycerides and inversely associated with HDL cholesterol.
Authors: R R Williams; D C Rao; R C Ellison; D K Arnett; G Heiss; A Oberman; J H Eckfeldt; M F Leppert; M A Province; S C Mockrin; S C Hunt Journal: Ann Epidemiol Date: 2000-08 Impact factor: 3.797
Authors: Amy E Taylor; Shah Ebrahim; Yoav Ben-Shlomo; Richard M Martin; Peter H Whincup; John W Yarnell; S Goya Wannamethee; Debbie A Lawlor Journal: Am J Clin Nutr Date: 2010-01-20 Impact factor: 7.045
Authors: John K Ninomiya; Gilbert L'Italien; Michael H Criqui; Joanna L Whyte; Anthony Gamst; Roland S Chen Journal: Circulation Date: 2003-12-15 Impact factor: 29.690
Authors: Fahim Abbasi; James W Chu; Tracey McLaughlin; Cindy Lamendola; Elizabeth T Leary; Gerald M Reaven Journal: Metabolism Date: 2004-02 Impact factor: 8.694
Authors: David Wormser; Stephen Kaptoge; Emanuele Di Angelantonio; Angela M Wood; Lisa Pennells; Alex Thompson; Nadeem Sarwar; Jorge R Kizer; Debbie A Lawlor; Børge G Nordestgaard; Paul Ridker; Veikko Salomaa; June Stevens; Mark Woodward; Naveed Sattar; Rory Collins; Simon G Thompson; Gary Whitlock; John Danesh Journal: Lancet Date: 2011-03-26 Impact factor: 79.321
Authors: Elizabeth Berry-Kravis; Rebecca Levin; Haroon Shah; Shaguna Mathur; Jennifer C Darnell; Bichun Ouyang Journal: Am J Med Genet A Date: 2014-11-25 Impact factor: 2.802
Authors: Qibin Qi; Garrett Strizich; David B Hanna; Rebeca E Giacinto; Sheila F Castañeda; Daniela Sotres-Alvarez; Amber Pirzada; Maria M Llabre; Neil Schneiderman; Larissa M Avilés-Santa; Robert C Kaplan Journal: Obesity (Silver Spring) Date: 2015-08-11 Impact factor: 5.002